| Dane A Ulett, DPM | |
|
2045 Peachtree Rd Ne Ste 810, Atlanta, GA 30309-1412 | |
| (404) 446-1890 | |
| (404) 446-1898 |
| Full Name | Dane A Ulett |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 25 Years |
| Location | 2045 Peachtree Rd Ne Ste 810, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992767594 | NPI | - | NPPES |
| 323277 | Other | GA | UNITED HEALTHCARE |
| 581994261 | Other | GA | CIGNA |
| 581994261 | Other | GA | GREAT WEST |
| 000947196K | Medicaid | GA | |
| 2847290 | Other | GA | AETNA |
| 336928 | Medicaid | GA | |
| 581994261 | Other | GA | COVENTRY HEALTHCARE |
| 52887103-033 | Other | GA | BLUE CROSS BLUE SH OF GA |
| 581994261 | Other | GA | PHCS |
| 581994261 | Other | GA | HUMANA |
| 000947196L | Medicaid | GA | |
| P00465728 | Other | GA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | POD000960 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Hospital | Atlanta, GA | Hospital |
| Provider Name | Village Podiatry Group Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1508846718 PECOS PAC ID: 4587646971 Enrollment ID: O20040601000776 |
News Archive
Intertek, (www.intertek.com), the leading provider of quality and safety services to a wide range of industries, has expanded its REACH services portfolio by providing comprehensive solutions to assist companies in complying with CLP, REACH, and GHS regulation requirements.
Despite challenges, it is feasible to collect and study the quality of outpatient cardiovascular care in a resource-limited environment like India, according to a pilot study published today in the Journal of the American Heart Association.
University of Alabama at Birmingham (UAB) psychologists have developed an animal model for the binge eating disorder, which affects an estimated one in 20 Americans.
A plan from Gentiva Health Services to buy Odyssey HealthCare for almost $1 billion would create the largest U.S. provider of home health and hospice care, The Associated Press reports. "The boards of both companies have approved the acquisition, which is expected to close in the third quarter, pending approval by regulators and Odyssey stockholders.
Oncothyreon Inc. today announced that Merck KGaA, Darmstadt, Germany, has initiated the international Phase 3 START2 study, which is designed to assess the efficacy and safety of the investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) in patients with unresectable, locally advanced Stage III non-small cell lung cancer (NSCLC).
› Verified 1 days ago
| Provider Name | Village Podiatry Group Ii Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1427540699 PECOS PAC ID: 7719218437 Enrollment ID: O20191010003075 |
News Archive
Intertek, (www.intertek.com), the leading provider of quality and safety services to a wide range of industries, has expanded its REACH services portfolio by providing comprehensive solutions to assist companies in complying with CLP, REACH, and GHS regulation requirements.
Despite challenges, it is feasible to collect and study the quality of outpatient cardiovascular care in a resource-limited environment like India, according to a pilot study published today in the Journal of the American Heart Association.
University of Alabama at Birmingham (UAB) psychologists have developed an animal model for the binge eating disorder, which affects an estimated one in 20 Americans.
A plan from Gentiva Health Services to buy Odyssey HealthCare for almost $1 billion would create the largest U.S. provider of home health and hospice care, The Associated Press reports. "The boards of both companies have approved the acquisition, which is expected to close in the third quarter, pending approval by regulators and Odyssey stockholders.
Oncothyreon Inc. today announced that Merck KGaA, Darmstadt, Germany, has initiated the international Phase 3 START2 study, which is designed to assess the efficacy and safety of the investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) in patients with unresectable, locally advanced Stage III non-small cell lung cancer (NSCLC).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dane A Ulett, DPM 900 Circle 75 Pkwy Se Ste 900, Atlanta, GA 30339-3084 Ph: (678) 426-2171 | Dane A Ulett, DPM 2045 Peachtree Rd Ne Ste 810, Atlanta, GA 30309-1412 Ph: (404) 446-1890 |
News Archive
Intertek, (www.intertek.com), the leading provider of quality and safety services to a wide range of industries, has expanded its REACH services portfolio by providing comprehensive solutions to assist companies in complying with CLP, REACH, and GHS regulation requirements.
Despite challenges, it is feasible to collect and study the quality of outpatient cardiovascular care in a resource-limited environment like India, according to a pilot study published today in the Journal of the American Heart Association.
University of Alabama at Birmingham (UAB) psychologists have developed an animal model for the binge eating disorder, which affects an estimated one in 20 Americans.
A plan from Gentiva Health Services to buy Odyssey HealthCare for almost $1 billion would create the largest U.S. provider of home health and hospice care, The Associated Press reports. "The boards of both companies have approved the acquisition, which is expected to close in the third quarter, pending approval by regulators and Odyssey stockholders.
Oncothyreon Inc. today announced that Merck KGaA, Darmstadt, Germany, has initiated the international Phase 3 START2 study, which is designed to assess the efficacy and safety of the investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) in patients with unresectable, locally advanced Stage III non-small cell lung cancer (NSCLC).
› Verified 1 days ago
Ayanda Dube, Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1364 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-727-5658 | |
Dr. Barbara S. Schlefman, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2789 Joel Pl, Atlanta, GA 30360 Phone: 770-604-3803 | |
Primera Foot & Ankle Centers Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1150 Hammond Dr Bldg E, Suite 600, Atlanta, GA 30328 Phone: 678-395-3628 Fax: 678-691-5164 | |
Dr. Frank Andrew Sinkoe, OPM DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1935 Cliff Valley Way Ne, 118, Atlanta, GA 30329 Phone: 404-329-5050 Fax: 404-329-5005 | |
Diabetic Foot Care Specialist Of Georgia Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 238 Walker St Sw, Unit #12, Atlanta, GA 30313 Phone: 404-759-6755 Fax: 334-271-3768 | |
Margo Angela Jimenez, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2295 Parklake Dr Ne Ste 150, Atlanta, GA 30345 Phone: 770-938-5974 Fax: 770-939-4450 | |
Mystic Medical, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 5555 Glenridge Connector, Suite 200, Atlanta, GA 30342 Phone: 404-351-0055 |